AMICOGEN

Biotech R&D Center

Biotech R&D Center

Amicogen Biotech R&D Center will grow as a global bio leader
with constant challenges and active investment.

Amicogen Biotech R&D Center has expanded its R&D field based on research capabilities and bio-platform technology,
expanding its R&D area and developing technologies for specialty industrial enzymes, enzymes and microbiologically based bio new materials.
Amicogen Biotech R&&D Center has expanded its R&D field based on research capabilities and bio-platform technology, expanding its R&D area
and developing technologies for specialty industrial enzymes, enzymes and microbiologically based bio new materials.

Our own management philosophy is to grow our company
through focusing on development of technology under any circumstances.

‘We will not develop the same or similar technology as the one of other companies’,
‘We want to develop the world's best technology’,
‘We do not research only for research’,
‘We want to develop technologies that can contribute to humanity’,
‘If we have a clear goal to develop, we will never give up’
We have our own principles for internal technology development as above.

Principle 3010 for innovative R&D

The number of researchers in Amicogen accounts for 30% of all employees.
This has not changed since the foundation of Amicogen on 29 May 2000 and will not change in the future either.
Amicogen Biotech R&D Center will lead industrial biotechnology to develop new technologies,
that drive the development of humanity, society, one step ahead of the others.

Thesis and Patents

Since its foundation on May 29, 2000, Amicogen Biotech R&D Center has obtained patents being recognized its inventive steps and the novelty of the developmental technologies of the evolution of the molecular gene. Based on this, we focus on the development of various industrial specialty enzymes, including enzymes (CX), necessary for the production of Cepha antibiotics material (7-ACA) and we have the related patents.

By expanding the special enzyme technology, we carry out researches for getting domestic and overseas patents registration through the development of bio new materials (N-acetylglucosamine, D-chiro-inositol and pinitol, collagen peptide and collagen tripeptide, chitosan, citrine etc.) and resin for protein purification (Protein A-resin etc.).